The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
The FDA setback highlights ongoing tensions between patient needs, regulatory processes, and the use of real-world evidence in evaluating treatments for rare diseases
RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment
The Fast Track Designation was supported by nonclinical data as well as clinical results from the ongoing Phase I/IIa trial evaluating the safety and tolerability
The acquisition will follow the planned separation of Avidity’s early-stage precision cardiology programs into a new, independent company
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
Subscribe To Our Newsletter & Stay Updated
